Clinical Study
Clinical Characteristics of Nocardia Infection in Patients with Rheumatic Diseases
Table 1
Demographics and characteristics of 10 rheumatic disease patients with Nocardia infection.
| | Case no. | Sex | Age | Underlying rheumatic disease | Treatment periods for rheumatic disease (years) | Doses of prednisolone (mg/day) | Other immunosuppressant | TMP-SMZ prophylaxis |
| | 1 | M | 70 | Behçet’s disease | >10 | 20 | | No | | 2 | F | 50 | SLE | 7 | 27.5 | AZT | No | | 3 | M | 79 | Sjögren’s syndrome | 1 | 20 | | No | | 4 | F | 77 | Granulomatosis with polyangiitis | 9 | 15 | | No | | 5 | F | 60 | Adult-onset Still’s disease | 0.3 | 30 | CyA | No | | 6 | M | 74 | Microscopic polyangiitis | >10 | 4.5 | AZT | Yes | | 7 | F | 67 | SLE | >10 | 15 | | No | | 8 | F | 40 | Microscopic polyangiitis | 7 | 22.5 | IVCY | No | | 9 | M | 69 | Microscopic polyangiitis | 5 | 25 | | No | | 10 | M | 62 | RA with vasculitis | >10 | 17.5 | AZT | No |
|
|
SLE: systemic lupus erythematosus; RA: rheumatoid arthritis; AZT: azathioprine; CyA: cyclosporine; IVCY: intravenous administration of cyclophosphamide; TMP-SMZ: Trimethoprim-sulfamethoxazole.
|
